Resulting from More than a Decade of Clinical Research, Company Unveils Non-Invasive Approach to Identify, and New Care Pathways to Address Heart Disease Using Artificial Intelligence NEW YORK–(BUSINESS WIRE)–Cleerly, the company creating a new standard of care for heart disease, launched today with $43 million in Series B funding and […]